6 [Relationship between letrozole administration during the luteal phase after oocyte retrieval and the early-stage ovarian hyperstimulation syndrome oocurrence].

7 Fish intake and ovarian cancer risk: a meta-analysis of 15 case-control and cohort studies.

8 Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.

9 Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel.

10 Unusual Case of Malignant Struma Ovarii and Cervical Thyroid Cancer Preceded by Ovarian Teratoma: Case Report and Review of the Literature

11 Structural studies of a water insoluble β-glucan from Pleurotus djamor and its cytotoxic effect against PA1, ovarian carcinoma cells.

12 Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.

13 Acupuncture for diminished ovarian reserve: Protocol for a systematic review and meta-analysis.

14 Autumnal fluxes of CH<inf>4</inf> and CO<inf>2</inf> from Mediterranean reed wetland based on eddy covariance and chamber methods

15 Generation of the 1H in H2O neutron thermal scattering law covariance matrix of the CAB model

16 Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study.

17 Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.

18 The Genetics of Non-Syndromic Primary Ovarian Insufficiency: A Systematic Review.

19 [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer].

20 Methane and carbon dioxide fluxes over a lake: comparison between eddy covariance, floating chambers and boundary layer method

21 Effect of Abelmoschus esculentus powder on ovarian histology, expression of apoptotic genes and oxidative stress in diabetic rats fed with high fat diet

22 Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles

23 MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.

24 Premature ovarian insufficiency and early depletion of the ovarian reserve in the monogenic Mulibrey nanism disorder

25 Meeting report from the 2018 12th Biennial Ovarian Cancer Research Symposium detection and prevention of ovarian cancer.

26 Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.

27 EGFR inhibition studies by hybrid scaffolds for their activity against ovarian cancer.

28 Phytochemicals in the treatment of ovarian cancer.

29 Quality of Life Assessment by the Endometriosis Health Profile (EHP-30) Questionnaire Prior to Treatment for Ovarian Endometriosis in Brazilian Women.

30 MicroRNA-21 as a biomarker for ovarian cancer detection

31 Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1.

32 Patterns of ovarian cancer and uterine cancer mortality and incidence in the contiguous USA.

33 Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer

34 Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells

35 Discovery of HB-EGF binding peptides and their functional characterization in ovarian cancer cell lines

36 Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells

37 Chemotherapeutic Efficacy of Implantable Antineoplastic-Treatment Protocols in an Optimal Mouse Model for Human Ovarian Carcinoma Cell Targeting

38 Heterocoagulation of polysaccharide-coated platinum nanoparticles with ovarian-cancer cells

39 Prior uterine myoma and risk of ovarian cancer: a population-based case-control study.

40 Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer.

41 Low-Dose Tacrolimus Prevents Dysregulated Peri-Conceptional Ovarian and Systemic Immune Cellular Homeostasis in Subjects with PCOS

42 MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.

43 Estimating a covariance matrix for market risk management and the case of credit default swaps

44 Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.

45 [Medical treatment in ovarian cancers newly diagnosed: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].

46 Dramatic response to Laetrile and cannabidiol (CBD)oil in a patient with metastatic low grade serous ovarian carcinoma

47 Experience of using time lapse microscopy in the IVF program in patients with good ovarian reserve.

48 Rare variants in FANCA induce premature ovarian insufficiency.

49 Dynamics of ovarian maturation during the reproductive cycle of Metynnis maculatus, a reservoir invasive fish species (Teleostei: Characiformes)

50 IMMUNODETECTION AND QUANTIFICATION OF ENZYMATIC MARKERS IN THECA CELLS: THE EARLY PROCESS OF OVARIAN STEROIDOGENESIS.

51 Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.

52 Complications and Survivorship Trends After Primary Debulking Surgery for Ovarian Cancer.

53 Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: a phase II study of the Gynecologic Oncology Group.

54 Management of bone health in women with premature ovarian insufficiency: Systematic appraisal of clinical practice guidelines and algorithm development.

55 Quantifying cadherin mechanotransduction machinery assembly/disassembly dynamics using fluorescence covariance analysis

56 Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)

57 Blind Source Separation Based on Covariance Ratio and Artificial Bee Colony Algorithm

58 Gap-filling approaches for eddy covariance methane fluxes: A comparison of three machine learning algorithms and a traditional method with principal component analysis.

59 Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer.

60 ICSI does not offer any benefit over conventional IVF across different ovarian response categories in non-male factor infertility: a European multicenter analysis.

61 Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.

62 Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model.

63 Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.

64 ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.

65 AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.

66 Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?

67 Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study

68 Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment.

69 Gemcitabine for recurrent ovarian cancer - a systematic review and meta-analysis.

70 Correction to: ICSI does not offer any benefit over conventional IVF across different ovarian response categories in non-male factor infertility: a European multicenter analysis.

71 Ovarian stimulated cycles reduce protection of follicular fluid against free radicals.

72 Doxorubicin-induced toxicity to 3D-cultured rat ovarian follicles on a microfluidic chip.

73 Directional freezing of ovarian tissue and freeze-drying of stem cells for fertility preservation

74 Utility of the “floating ball sign” in diagnosis of ovarian cystic teratoma

75 Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients.

76 Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR

77 Ovarian stimulation does not influence the uterine immune environment in healthy infertile women.

78 Corrigendum to “Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution” (Surgical Oncology (2019) 31 (8–13), (S0960740419301823), (10.1016/j.suronc.2019.08.006))

79 Covariance Prediction in Large Portfolio Allocation

80 An Analysis of Conditional Dependencies of Covariance Matrices for Economic Processes in Selected EU Countries

81 Hard and soft X-ray imaging to resolve human ovarian cortical structures.

82 Quarkonia and heavy-light mesons in a covariant quark model

83 Bisphenol A and its derivatives decrease expression of chemerin, which reverses its stimulatory action in ovarian cancer cells

84 NOS1 upregulates ABCG2 expression contributing to DDP chemoresistance in ovarian cancer cells

85 Identification of a New Theca/Interstitial Cell-Specific Gene and Its Biological Role in Growth of Mouse Ovarian Follicles at the Gonadotropin-Independent Stage.

86 Intra-abdominal tuberculosis masquerading as ovarian carcinoma.

87 A diagnostic approach for differentiating abdominal tuberculosis from ovarian malignancy: a case series and literature review.

88 P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study.

89 Acupuncture Reduces Apoptosis of Granulosa Cells in Rats with Premature Ovarian Failure Via Restoring the PI3K/Akt Signaling Pathway

90 Premature ovarian insufficiency and autoimmune diseases.

91 GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.

92 Development and Evaluation of Geostatistical Methods for Non-Euclidean-Based Spatial Covariance Matrices.

93 Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis.

94 Cognitive changes across the menopause transition: A longitudinal evaluation of the impact of age and ovarian status on spatial memory.

95 Psychosocial Vulnerability, Resilience Resources, and Coping with Infertility: A Longitudinal Model of Adjustment to Primary Ovarian Insufficiency.

96 A Monte Carlo Comparison Study of the Power of the Analysis of Covariance, Simple Difference, and Residual Change Scores in Testing Two-Wave Data.

97 A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles.

98 Iron(III)-salophene: an organometallic compound with selective cytotoxic and anti-proliferative properties in platinum-resistant ovarian cancer cells.

99 TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.

100 Increased temperature-related adeno-associated virus vectors transduction of ovarian cancer cells - essential signatures of AAV receptor and heat shock proteins.

101 Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.

Keyword Connections

Journals

Research Groups

Bibliographies